Details for Patent: 11,529,368
✉ Email this page to a colleague
Which drugs does patent 11,529,368 protect, and when does it expire?
Patent 11,529,368 protects PLENVU and is included in one NDA.
This patent has sixty-nine patent family members in thirty-four countries.
Drugs Protected by US Patent 11,529,368
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate | FOR SOLUTION;ORAL | 209381-001 | May 4, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,529,368
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 085712 | ⤷ Try a Trial | |||
Argentina | 124122 | ⤷ Try a Trial | |||
Australia | 2012228065 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |